NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma. [electronic resource]
Producer: 20080304Description: 69-77 p. digitalISSN:- 0301-472X
- Adjuvants, Immunologic -- administration & dosage
- Adult
- Antibodies, Monoclonal -- immunology
- Antibodies, Monoclonal, Murine-Derived
- Antibody-Dependent Cell Cytotoxicity -- drug effects
- Burkitt Lymphoma -- pathology
- Cell Line, Tumor -- drug effects
- Drug Synergism
- Humans
- Interferon-gamma -- biosynthesis
- Interleukin-15 -- administration & dosage
- Killer Cells, Natural -- drug effects
- Leukocytes, Mononuclear -- drug effects
- Lymphocyte Activation -- drug effects
- Oligodeoxyribonucleotides -- administration & dosage
- Rituximab
- Toll-Like Receptor 9 -- agonists
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.